Defunct Company
Total Trials
7
As Lead Sponsor
As Collaborator
0
Total Enrollment
4,351
NCT00288275
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
Phase: N/A
Role: Lead Sponsor
Start: Jul 31, 2004
Completion: Oct 31, 2012
NCT00669422
ChemoFx® PRO - A Post-Market Data Collection Study
Start: Oct 31, 2006
NCT01049126
Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients
Start: Jul 31, 2009
Completion: Feb 28, 2010
NCT01048814
Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases
Start: Aug 31, 2009
Completion: Jun 30, 2011
NCT01007890
Prediction of Response to Neoadjuvant Chemotherapy in Women With Operable Breast Cancer
Start: Nov 30, 2009
NCT01271959
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Start: Nov 30, 2010
NCT01450553
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
Start: Oct 31, 2011
Completion: Not specified